Contact
SK
International grants: |
|
| Exploring the molecular determinants and functional role of T-type channel dimerization (2018 –2020) Principal Investigator: Ľubica Lacinová |
|
Slovak Research and Development Agency (SRDA): |
|
Coordinated at IMPG SAS |
|
 |
APVV-15-0388 Prenatal and postnatal effects of ? and µ opioid receptor ligands on the hippocampal development and function (2016 – 2020) Principal Investigator: Ľubica Lacinová |
 |
APVV-14-0334 Possible dual function of P-glycoprotein in leukemia cells: efflux pump and regulatory protein (2015-2018) Principal Investigator: Zdena Sulová |
Collaborative projects |
|
| APVV-16-0439 The application of myrosinase for sulforaphane activation in development of a novel product exhibiting cancer prevention effects (2017-2021) Principal Investigator (IMPG SAS): Zdena Sulová |
|
| APVV-15-0641 Smart MoS2 platform for cancer diagnosis and targeted treatment (2016-2020) Principal Investigator (IP SAS): Peter Šiffalovič Team leader at IMPG SAS: Albert Breier |
|
| APVV-15-0372 Novel synergistic antitumour properties of nuclear retinoid X receptor (RXR) agonists as a consequence of the conditional RXR-RAR heterodimer formation in human breast cancer cells (2016-2020) Principal Investigator (IEE BMC SAS): Július Brtko Team leader at IMPG SAS: Zdena Sulová |
|
|
APVV-15-0303 Defense mechanisms of neoplastic cells against chemical stress (2016-2020) Principal Investigator(FCHFT STU): Albert Breier Team leader at IMPG SAS: Zdena Sulová |
| APVV-14-0753 Biochips and biosensors for glycorecognition, their development, preparation and application in cancer research (2015-2019) Principal Investigator (ICH SAS): Jaroslav Katrlík Team leader at IMPG SAS: Zdena Sulová |
|
Scientific Grant Agency of MESRaS and SAS (VEGA): |
|
| VEGA 2/0090/18 Vzťah mikroarchitektúry mitochondriálnej siete a jej funkčného spriahnutia v kardiomyocytoch (2018 – 2021) Principal Investigator: Zuzana Tomášková |
|
 |
VEGA 2/0057/18 Analyses of allele-specific regulation of CD33 expression (2018 – 2021) Principal Investigator: Jana Královičová |
| VEGA 2/0157/18 The effect of polyphenols on the functions of signal proteins involved in proteins N-glycosylation in the endoplasmic reticulum of leukemia cells, depending on the expression of P-glycoprotein (2018-2021) Principal Investigator: Viera Boháčová |
|
|
VEGA 2/0122/17 Study of changes in expression of some regulatory and functional proteins connected with the presence of P-gp protein in leukemic cells (2017-2020) Principal Investigator: Zdena Sulová |
 |
VEGA 2/0086/17 Luminal regulation of the cardiac ryanodine receptor and its molecular mechanisms (2017 – 2019) Principal Investigator: Marta Gaburjáková |
|
VEGA 2/0156/16 The effect of endoplasmic reticulum stress inductors and proteaosome inhibitors on leukemia cell line L1210, SKM-1 and MOLM-13 with induced P-glycoprotein overexpression (2016-2018) Principal Investigator: Mário Šereš |
 |
VEGA 2/0107/16 Novel pathways of N-type (CaV2.2) calcium channels regulation (2016 – 2018) Principal Investigator: Ľubica Lacinová |
|
VEGA 2/0028/15 Changes of leukemia cells drug sensitivity induced by changes of membrane drug transporters expression profile (2015-2018) Principal Investigator: Albert Breier |
 |
VEGA 2/0046/18 Investigation of the mechanism of action of novel putative antidepressant drugs: pyridoindole derivatives and trace amine-associated receptor-1 (TAAR1) ligands (2018 – 2021) Principal Investigator: Eliyahu Dremencov |
 |
VEGA 2/0011/18 Regulation of the cardiac ryanodine receptor phosphorylated by protein kinase A (2018 – 2020) Principal Investigator: Jana Gaburjáková |
Other national projects: |
|
 |
SAS Stipend Role of neurosecretory neurons and calcium signalling in depression and addictive behaviour: Assessment by in-vivo electrophysiology (2013 – 2017) Principal Investigator: Eliyahu Dremencov |